| WARRANTS AND OPTIONS |
NOTE
7 - WARRANTS AND OPTIONS
a)
Warrants
| |
(i) |
Warrant
transactions for the three months ended March 31, 2026, and for the year ended December 31, 2025, are as follows: |
SCHEDULE OF WARRANTS TRANSACTIONS
| | |
Number | | |
Weighted
Average Exercise Price | |
| Balance,
January 1, 2025 | |
| 4,928,329 | | |
$ | 6.17 | |
| Expiry of warrants | |
| (721,239 | ) | |
| | |
| Exercise of warrants | |
| (3,474,595 | ) | |
| | |
| Warrants issued in
the January 2025 Registered Direct Offering and September 2025 underwritten public offering | |
| 554,313 | | |
| | |
| Balance, December 31,
2025 | |
| 1,286,808 | | |
$ | 13.39 | |
| Exercise of warrants | |
| (252,967 | ) | |
| | |
| Balance,
March 31, 2026 | |
| 1,033,841 | | |
$ | 16.15 | |
During
the three-month period ended March 31, 2026, the Company issued 252,967 shares in respect of 252,967 warrants that were exercised for
total proceeds of $946.
(ii) As
at March 31, 2026, the Company had outstanding warrants, enabling the holders to acquire Common Shares as follows:
SCHEDULE OF OUTSTANDING WARRANTS
March
31, 2026 | | |
Expiry
date | |
Exercise
price | | |
Exercise
price (USD) | |
| | 88,440 | | |
April 18, 2026 | |
ILS | 72.563 | | |
$ | 22.93 | |
| | 433,825 | | |
May 28, 2026 | |
ILS | 72.563 | | |
$ | 22.93 | |
| | 3,200 | | |
October 2, 2026 | |
USD | 1.88 | | |
$ | 1.88 | |
| | 183,751 | | |
January 29, 2030 | |
USD | 8.00 | | |
$ | 8.00 | |
| | 324,625 | | |
September 16, 2030 | |
USD | 10.00 | | |
$ | 10.00 | |
| | 1,033,841 | | |
| |
| | | |
| | |
A2Z
CUST2MATE SOLUTIONS CORP.
NOTES
TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2026
(Unaudited)
(Expressed
in thousands of US Dollars, except per share data)
NOTE
7 - WARRANTS AND OPTIONS (CONTINUED)
b)
Stock Options
(i) Stock
option transactions for the three months ended March 31, 2026, and for the year ending December 31, 2025, are as follows:
SCHEDULE OF STOCK OPTION TRANSACTIONS
| | |
Number | | |
Weighted
Average Exercise Price (CAD) | | |
Weighted
Average Exercise Price (USD) | |
| Balance
January 1, 2025 | |
| 1,756,670 | | |
$ | 5.39 | | |
$ | 3.75 | |
| Options cancelled | |
| (127,668 | ) | |
| | | |
| | |
| Options exercised | |
| (225,332 | ) | |
| | | |
| | |
| Options granted | |
| 2,863,500 | | |
| | | |
| | |
| Balance
December 31, 2025 | |
| 4,267,170 | | |
$ | 6.14 | | |
$ | 8.41 | |
| Options cancelled | |
| (70,000 | ) | |
| | | |
| | |
| Options exercised | |
| (4,000 | ) | |
| | | |
| | |
| Options granted | |
| 25,000 | | |
| | | |
| | |
| Balance
March 31, 2026 | |
| 4,218,170 | | |
$ | 8.52 | | |
$ | 6.11 | |
(ii) As
at March 31, 2026, the Company had outstanding stock options, enabling the holders to acquire Common Shares as follows:
SCHEDULE
OF OUTSTANDING STOCK OPTIONS
Outstanding
as of
March 31, 2026 | | |
Exercisable
as of
March 31, 2026 | | |
Expiry
date | |
Exercise
price (CAD) | | |
Exercise
price (USD) | |
| | 20,000 | | |
| 20,000 | | |
June 3, 2026 | |
CAD | 21.00 | | |
$ | 15.07 | |
| | 6,670 | | |
| 6,670 | | |
October 28, 2026 | |
CAD | 20.00 | | |
$ | 14.35 | |
| | 360,000 | | |
| 360,000 | | |
August 2, 2032 | |
CAD | 8.90 | | |
$ | 6.38 | |
| | 120,000 | | |
| 120,000 | | |
August 21, 2032 | |
CAD | 10.00 | | |
$ | 7.17 | |
| | 220,000 | | |
| 220,000 | | |
January 4, 2033 | |
CAD | 4.13 | | |
$ | 2.96 | |
| | 100,000 | | |
| 100,000 | | |
January 4, 2033 | |
CAD | 4.13 | | |
$ | 2.96 | |
| | 40,000 | | |
| 40,000 | | |
November 25, 2027 | |
CAD | 5.03 | | |
$ | 3.60 | |
| | 99,000 | | |
| 91,000 | | |
April 18, 2033 | |
CAD | 4.00 | | |
$ | 2.87 | |
| | 441,000 | | |
| 146,333 | | |
August 14, 2034 | |
CAD | 2.47 | | |
$ | 1.78 | |
| | 105,000 | | |
| 35,000 | | |
January 15, 2035 | |
CAD | 8.92 | | |
$ | 6.40 | |
| | 500,000 | | |
| 500,000 | | |
February 2, 2035 | |
CAD | 8.92 | | |
$ | 6.40 | |
| | 30,000 | | |
| 10,000 | | |
June 20, 2035 | |
CAD | 2.47 | | |
$ | 1.775 | |
| | 177,000 | | |
| - | | |
June 20, 2035 | |
CAD | 8.92 | | |
$ | 6.40 | |
| | 224,000 | | |
| 6,667 | | |
October 9, 2035 | |
CAD | 11.15 | | |
$ | 8.00 | |
| | 500,000 | | |
| 500,000 | | |
December 30, 2035 | |
CAD | 8.36 | | |
$ | 6.00 | |
| | 1,250,500 | | |
| 805,000 | | |
December 30, 2035 | |
CAD | 11.15 | | |
$ | 8.00 | |
| | 25,000 | | |
| - | | |
March 27, 2036 | |
CAD | 11.15 | | |
$ | 8.00 | |
| | 4,218,170 | | |
| 2,960,670 | | |
| |
| | | |
| | |
Share-based
compensation expense is recognized over the vesting period of options. During the three months ended March 31, 2026, share-based compensation
of $1,060 was recognized and charged to the Consolidated Statement of Comprehensive Loss (March 31, 2025 – $3,349).
A2Z
CUST2MATE SOLUTIONS CORP.
NOTES
TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2026
(Unaudited)
(Expressed
in thousands of US Dollars, except per share data)
NOTE
7 - WARRANTS AND OPTIONS (CONTINUED)
c)
RSUs
RSUs
transactions for the three months ended March 31, 2026, and for the year ending December 31, 2025, are as follows:
SCHEDULE
OF RSU’S TRANSACTIONS
| | |
Number | |
| Balance, January 1, 2025 | |
| 110,667 | |
| RSUs granted | |
| 1,545,000 | |
| Expiry of RSUs | |
| (6,000 | ) |
| Exercise of RSUs | |
| (219,667 | ) |
| Balance, December 31,
2025 | |
| 1,430,000 | |
| Exercise of RSUs | |
| (400,000 | ) |
| Balance, March 31,
2026 | |
| 1,030,000 | |
Total
exercisable RSUs as of March 31, 2026, are 500,000,
another 500,000
RSU’s are milestone based RSU’s for which the milestones have not yet been achieved and 30,000 have not
yet vested. During the three months ended March 31, 2026, share-based compensation
of $815
was recognized and charged to the Consolidated Statement of
Comprehensive Loss (March 31, 2025 – $520).
A2Z
CUST2MATE SOLUTIONS CORP.
NOTES
TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2026
(Unaudited)
(Expressed
in Thousands of US Dollars, except per share data)
|